Skip to content

Nipple Sparing Mastectomy - Cosmetic Outcomes

Preservation of the Nipple Areolar Complex With Skin Sparing Mastectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01002014
Enrollment
75
Registered
2009-10-27
Start date
2009-01-21
Completion date
2018-09-20
Last updated
2022-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Breast Reconstruction, Cosmesis

Keywords

Breast Cancer, Skin Sparing Mastectomy, Breast Cancer Prophylaxis, Nipple Sparing Mastectomy, Nipple Areolar Complex, Mastectomy, Breast Reconstruction, Local recurrence following nipple sparing mastectomy, Cosmetic outcomes following nipple sparing mastectomy, Complications following nipple sparing mastectomy

Brief summary

The purpose of this study is to observe the cosmetic outcomes, patient satisfaction, and complications after skin sparing mastectomy with preservation of the nipple areolar complex.

Detailed description

The outcomes will be observed in patients with both known cancer diagnosis and in those with indications for prophylactic mastectomy. The cosmetic appearance and complications will be followed through several post operative visits throughout the duration of the study. This study is conducted in conjunction with the plastic and reconstructive surgeons who will be performing the breast reconstruction procedures. Patient satisfaction will be measured via survey format. In addition, local recurrence rates will be compared to patients undergoing traditional mastectomy.

Interventions

Skin sparing mastectomy with preservation of the nipple areolar complex

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients requiring mastectomy for cancer and/or prophylaxis * Age greater than or equal to 18 at time of surgery * BMI less than or equal to 35 * If mastectomy is indicated for removal of breast cancer, tumor is clinically T1 or T2

Exclusion criteria

* Currently smoking * Prior radiation to the affected breast * Systemic lupus erythematosus * Central tumor location and/or tumor within 2 cm of NAC * Paget's disease of the nipple * Clinical evidence of tumor involvement in the nipple * Clinical evidence of axillary nodal tumor involvement * Lymphovascular invasion of the tumor on core biopsy

Design outcomes

Primary

MeasureTime frame
Cosmetic AppearanceFirst Post Operative year
Patient SatisfactionFirst Post Operative Year
Presence of tumor in nipple areolar complex frozen sectionDuration of Study
Presence of tumor in nipple areolar complex permanent histologyDuration of study

Secondary

MeasureTime frame
ComplicationsFirst Post Operative year
Local RecurrenceOne year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026